Keyphrases
Population-based
100%
Antidepressants
100%
Cataract
100%
Nested Case-control Study
100%
Confidence Interval
63%
Adjusted Odds Ratio
45%
Binding Affinity
27%
Serotonin Transporter
27%
Selective Serotonin Reuptake Inhibitors
18%
Antidepressant Exposure
18%
Taiwan
9%
Environmental Factors
9%
Substance Use
9%
National Health Insurance Research Database (NHIRD)
9%
Obesity
9%
Confounding Factors
9%
Radiation Exposure
9%
Continued Use
9%
Duration of Use
9%
Usage Factor
9%
Multiple Drugs
9%
Family History
9%
Fluoxetine
9%
Fluvoxamine
9%
Sun Exposure
9%
Conditional Logistic Regression Analysis
9%
Drug Users
9%
Venlafaxine
9%
Serotonin-norepinephrine Reuptake Inhibitors
9%
Biochemistry, Genetics and Molecular Biology
Binding Affinity
100%
Case-Control Study
100%
Serotonin Transporter
100%
Selective Serotonin Reuptake Inhibitor
66%
Substance Use
33%
Fluoxetine
33%
Fluvoxamine
33%
Venlafaxine
33%
Serotonin-Norepinephrine Reuptake Inhibitor
33%
Medicine and Dentistry
Case-Control Study
100%
Antidepressant
100%
Cataract
100%
Odds Ratio
45%
Binding Affinity
27%
Serotonin Transporter
27%
Selective Serotonin Reuptake Inhibitor
18%
Substance Use
9%
Logistic Regression Analysis
9%
Environmental Factor
9%
Radiation Exposure
9%
Family History
9%
Venlafaxine
9%
Fluoxetine
9%
Fluvoxamine
9%
Pharmacology, Toxicology and Pharmaceutical Science
Antidepressant
100%
Case-Control Study
100%
Cataract
100%
Serotonin Transporter
27%
Selective Serotonin Reuptake Inhibitor
18%
Radiation Exposure
9%
Fluoxetine
9%
Venlafaxine
9%
Fluvoxamine
9%
Neuroscience
Antidepressant
100%
Cataract
100%
Binding Affinity
27%
Serotonin Transporter
27%
Selective Serotonin Reuptake Inhibitor
18%
Substance Abuse
9%
Fluoxetine
9%
Venlafaxine
9%
Fluvoxamine
9%